Stoboclo 60 mg

Stoboclo 60 mg is a medicine authorised by Swissmedic under authorisation number 70199. The authorisation holder is IQONE HEALTHCARE SWITZERLAND SA. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 August 2025 and the authorisation is limited until 18 August 2030. ATC code M05BX04 places the medicine in the group Drugs for treatment of bone diseases.

  • Dispensing category B
  • Authorisation number 70199
  • ATC M05BX04
  • Biotechnological medicines
Authorisation data
Authorisation number70199
NameStoboclo 60 mg
Full nameStoboclo 60 mg, solution injectable en seringue préremplie
Authorisation holderIQONE HEALTHCARE SWITZERLAND SA
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeM05BX04
First authorisation19 August 2025
Authorisation validity18 August 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Stoboclo 60 mg, solution injectable en seringue préremplieB19 August 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Fertigspritze(n)M05BX0407.99.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Stoboclo 60 mg authorised in Switzerland?

Yes. Stoboclo 60 mg is authorised by Swissmedic under authorisation number 70199, data as of 01 September 2026. The authorisation is limited until 18 August 2030.

Which dispensing category does Stoboclo 60 mg have?

Stoboclo 60 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Stoboclo 60 mg?

The authorisation holder is IQONE HEALTHCARE SWITZERLAND SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com